WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is a concentration step, which enriches the … WebSummary Overview Number of Founded Organizations 1 CB Rank (Person) 672,540 Gender Male Christopher Stanley is the co-founder of CynapseDx. Jobs Number of Current Jobs 1 Christopher Stanley is the Co-Founder & CTO at CynapseDx. CynapseDx Co-Founder & CTO Recent News and Activity There is no recent news or activity for this profile.

CynapseDx Stock Price, Funding, Valuation, Revenue & Financial …

WebCynapseDx's key executives include Damian Bond and 2 others. Damian Bond Chief Executive Peter Foster Chairman Christopher Stanley Chief Technology Officer Source: cynapsedx.com Report incorrect company information Key Executive Tracking Receive notifications of key executive changes Get started Executives of similar companies Vivid … WebCynapseDx (formerly CellCap Technologies) is a company that develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from neurodegenerative diseases. View company Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via … cycloplegics and mydriatics

Top Gemelli Biotech Competitors and Alternatives Craft.co

http://forum.cynapsedx.com/ WebCynapseDx has incorporated three technical enhancements to allow us to measure the oligomeric and aggregated forms of these biomarker proteins in blood. Immunoconcentration. We use antibody-coated magnetic … WebCynapseDx has been developing products to isolate proteins or cells from whole blood since 2012. At the heart of our techniques is an antibody coated large ultra-dense … cyclopithecus